Inpatient Services

Glycemic Management – Comparison Framework

Best Practice Protocols

Current State: Glycemic management often varies across providers, units, and facilities. Protocols may be outdated, inconsistently applied, and differ from hospital to hospital—or even unit to unit—resulting in variability in care and outcomes.
JM2 Health Advantage: JM2 Health partners with healthcare leaders to implement proven, standardized protocols across all hospitals within a health system. Using the latest evidence-based clinical guidelines, we help hardwire best practices into daily workflow—supporting consistency, safety, and measurable performance.

Specialized Inpatient Glycemic Management

Current State: Glycemic control is often one task among many for busy inpatient teams. This can lead to reactive, inconsistent treatment and increase the likelihood of both hypoglycemia and hyperglycemia.
JM2 Health Advantage: JM2 Health supports the deployment of dedicated glycemic management specialists (APNs) who focus on patients with uncontrolled glucose and diabetes-related complications.
Their proactive daily oversight reduces glycemic excursions, improving patient safety and lowering the cost of care.

IV Insulin Software and Support

Current State: IV insulin management for critically ill patients is complex and high-risk. Hospitals may rely on manual processes, variable protocols, and inconsistent decision support—creating avoidable variability, safety risk, and staff burden.
JM2 Health Advantage: JM2 Health supports safe, standardized IV insulin management through seamless EHR integration and automated clinical decision support. This approach reduces variability in care, supports clinical teams managing critically ill patients, and has helped health systems achieve a clinically significant reduction in hypoglycemic events, improving patient safety and operational efficiency.

Discharge Planning

Current State: Discharge plans may lack diabetes-specific input, contributing to medication errors, poor glucose control at home, and preventable readmissions.
JM2 Health Advantage: JM2 Health-deployed APNs work directly with attending physicians and care teams to support safe, structured discharge planning, including medication review, insulin regimen recommendations, and a clear transition plan designed to reduce readmission risk.

Outpatient Education

Current State: Post-discharge education is often limited or inconsistent, leaving patients unsure how to manage their diabetes at home. Access to follow-up care may be delayed, unavailable, or unclear.
JM2 Health Advantage: JM2 Health provides the resources needed for health systems to implement an outpatient diabetes education and management program. These programs support primary care teams and provide the training, follow-up, and ongoing guidance patients need to succeed after leaving the hospital.

Inpatient Glycemic Management Program

Improving Safety, Reducing Risk, and Delivering Better Outcomes

Year after year, improper insulin dosing is responsible for the highest number of adverse drug events in every hospital.  Managing blood glucose in the hospital is one of the most critical components of patient safety. Both
hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar) significantly increase complications, length of stay, readmissions, and system-wide cost. As CMS strengthens its expectations for inpatient glycemic control, hospitals face growing pressure to maintain safe, compliant, and measurable outcomes. 

JM2 Health delivers a turnkey inpatient glycemic management program that combines specialized clinical staff, evidence-based protocols, and advanced technology to reduce variability, prevent complications, and elevate the quality of care.

Specialized Advanced Practice Nurses Integrated Into Your Hospital Team 

At the core of our inpatient service is a team of highly trained Advanced Practice Nurses (APNs) who specialize in diabetes and glycemic management. Working under the direction of attending physicians, our APNs provide real-time oversight of patients’ blood glucose levels throughout their hospital stay. 

APNs collaborate seamlessly with hospitalists, intensivists, surgeons, and nursing staff to: 

  • Prevent dangerous lows and highs through proactive monitoring 
  • Adjust insulin and glucose-lowering therapies using evidence-based protocols 
  • Respond immediately to clinical changes 
  • Reduce the burden on busy inpatient teams 
  • Improve communication across service lines 
  • Ensure safer transitions of care, including perioperative and discharge planning 

This high-touch model ensures patients receive expert guidance while physicians and nursing teams remain fully supported. 

Why Glycemic Control Matters in the Hospital 

Poor glycemic control is one of the most preventable causes of inpatient complications. Its impacts include: 

Hypoglycemia (Low Blood Sugar) 

  • Increased fall risk 
  • Neurologic injury 
  • Higher mortality 
  • Immediate clinical instability 

Hyperglycemia (High Blood Sugar) 

  • Higher infection rates 
  • Surgical complications 
  • Slower wound healing 
  • Longer length of stay and higher readmissions 

Both conditions contribute to avoidable costs, staff strain, and reduced quality performance. With CMS intensifying its focus on inpatient glycemic metrics, hospitals must meet higher expectations to protect reimbursement and maintain quality rankings. 

JM2 Health helps hospitals succeed under these evolving standards through a comprehensive, proven COLLOBORATIVE clinical model. 

A Proven JM2 Health Model: High-Touch Care + High-Tech Tools 

JM2 Health’s inpatient model integrates high-touch clinical support with the latest advancements in glycemic management technology and best-practice guidelines. 

Our program incorporates: 

  • Endocrinologist Leadership and Supervision 
  • Evidence-based insulin and medication management protocols 
  • Glucometric Dashboards at the health system, hospital and unit levels. 
  • Comprehensive new hire and annual education for Diabetes-focused APP staff 
  • Peer-reviewed, guideline-driven order sets 
  • FDA-cleared digital therapeutics supporting insulin dosing optimization and clinical decision-making 
  • Seamless communication between JM2 Health APNs and attending physicians 
  • Continuous glucose monitoring and trending to prevent severe hypoglycemia 
  • Comprehensive reporting aligned with CMS and hospital quality benchmarks 

This high-touch/high-tech approach enhances patient safety, creates standardization in care, and produces predictable outcomes across all inpatient units. 

 

Clinical, Operational, and Financial Impact 

Hospitals partnering with JM2 Health experience measurable improvements across critical domains: 

Clinical Improvements 

  • Significant reduction in severe hypoglycemic events 
  • More consistent glucose control across inpatient service lines 
  • Improved surgical and infection outcomes 
  • Improved steroid titrations 
  • Higher patient and provider satisfaction 

Operational Efficiency 

  • Reduced average length of stay 
  • Fewer 30-day readmissions 
  • Better bed utilization 
  • Less strain on nursing and physician teams 

Financial Value 

  • Avoided costs associated with glycemic complications 
  • Additional inpatient revenue through APN billing 
  • Strong protection against CMS penalties 
  • Proven, reliable economic return supported by real-world results 

 

Why Health Systems Choose JM2 Health 

Hospitals nationwide face increasing pressures: staffing shortages, tighter margins, tougher CMS quality standards, and rising patient complexity. JM2 Health provides a complete inpatient glycemic management solution that is: 

  • Turnkey and quickly deployable 
  • Led by experienced, highly specialized clinicians 
  • Rooted in the latest standards of care and national guidelines 
  • Designed to improve quality and safety while reducing costs 
  • Focused on measurable results and a sustainable, long-term partnership 

We integrate seamlessly into your workflows, empowering your clinicians and elevating the standard of inpatient diabetes care. 

Partner With JM2 Health 

If your hospital is working to reduce hypoglycemia, improve overall glycemic control, meet CMS requirements, or alleviate pressure on your clinical teams, JM2 Health can help. 

Let’s improve inpatient safety, quality, and financial performance — together. 

Contact us today to learn more about our Inpatient Glycemic Management Program. 

 

Inpatient Glycemic Management Program

Improving Safety, Reducing Risk, and Delivering Better Outcomes

Year after year, improper insulin dosing is responsible for the highest number of adverse drug events in every hospital. Managing blood glucose in the hospital is one of the most critical components of patient safety. Both hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar) significantly increase complications, length of stay, readmissions, and system-wide cost. As CMS strengthens its expectations for inpatient glycemic control, hospitals face growing pressure to maintain safe, compliant, and measurable outcomes.

JM2 Health delivers a turnkey inpatient glycemic management program that combines specialized clinical staff, evidence-based protocols, and advanced technology to reduce variability, prevent complications, and elevate the quality of care.

Specialized Advanced Practice Nurses Integrated Into Your Hospital Team

At the core of our inpatient service is a team of highly trained Advanced Practice Nurses (APNs) who specialize in diabetes and glycemic management. Working under the direction of attending physicians, our APNs provide real-time oversight of patients’ blood glucose levels throughout their hospital stay.

APNs collaborate seamlessly with hospitalists, intensivists, surgeons, and nursing staff to:

  • Prevent dangerous lows and highs through proactive monitoring

  • Adjust insulin and glucose-lowering therapies using evidence-based protocols

  • Respond immediately to clinical changes

  • Reduce the burden on busy inpatient teams

  • Improve communication across service lines

  • Ensure safer transitions of care, including perioperative and discharge planning

This high-touch model ensures patients receive expert guidance while physicians and nursing teams remain fully supported.

Why Glycemic Control Matters in the Hospital

Poor glycemic control is one of the most preventable causes of inpatient complications. Its impacts include:

Hypoglycemia (Low Blood Sugar)
  • Increased fall risk

  • Neurologic injury

  • Higher mortality

  • Immediate clinical instability

Hyperglycemia (High Blood Sugar)
  • Higher infection rates

  • Surgical complications

  • Slower wound healing

  • Longer length of stay and higher readmissions

Both conditions contribute to avoidable costs, staff strain, and reduced quality performance. With CMS intensifying its focus on inpatient glycemic metrics, hospitals must meet higher expectations to protect reimbursement and maintain quality rankings.
JM2 Health helps hospitals succeed under these evolving standards through a comprehensive, proven COLLOBORATIVE clinical model.

A Proven JM2 Health Model: High-Touch Care + High-Tech Tools

JM2 Health’s inpatient model integrates high-touch clinical support with the latest advancements in glycemic management technology and best-practice guidelines.

Our program incorporates:

  • Endocrinologist Leadership and Supervision

  • Evidence-based insulin and medication management protocols

  • Glucometric Dashboards at the health system, hospital and unit levels.

  • Comprehensive new hire and annual education for Diabetes-focused APP staff

  • Peer-reviewed, guideline-driven order sets

  • FDA-cleared digital therapeutics supporting insulin dosing optimization and clinical decision-making

  • Seamless communication between JM2 Health APNs and attending physicians

  • Continuous glucose monitoring and trending to prevent severe hypoglycemia

  • Comprehensive reporting aligned with CMS and hospital quality benchmarks

This high-touch/high-tech approach enhances patient safety, creates standardization in care, and produces predictable outcomes across all inpatient units.

Clinical, Operational, and Financial Impact

Hospitals partnering with JM2 Health experience measurable improvements across critical domains:

Clinical Improvements
  • Significant reduction in severe hypoglycemic events

  • More consistent glucose control across inpatient service lines

  • Improved surgical and infection outcomes

  • Improved steroid titrations

  • Higher patient and provider satisfaction

Operational Efficiency
  • Reduced average length of stay

  • Fewer 30-day readmissions

  • Better bed utilization

  • Less strain on nursing and physician teams

Financial Value
  • Avoided costs associated with glycemic complications

  • Additional inpatient revenue through APN billing

  • Strong protection against CMS penalties

  • Proven, reliable economic return supported by real-world results

Why Health Systems Choose JM2 Health

Hospitals nationwide face increasing pressures: staffing shortages, tighter margins, tougher CMS quality standards, and rising patient complexity. JM2 Health provides a complete inpatient glycemic management solution that is:

  • Turnkey and quickly deployable

  • Led by experienced, highly specialized clinicians

  • Rooted in the latest standards of care and national guidelines

  • Designed to improve quality and safety while reducing costs

  • Focused on measurable results and a sustainable, long-term partnership

We integrate seamlessly into your workflows, empowering your clinicians and elevating the standard of inpatient diabetes care.

Partner With JM2 Health

If your hospital is working to reduce hypoglycemia, improve overall glycemic control, meet CMS requirements, or alleviate pressure on your clinical teams, JM2 Health can help.

Let’s improve inpatient safety, quality, and financial performance — together.

Contact us today to learn more about our Inpatient Glycemic Management Program.

“JM2 Health is revolutionizing diabetes care for hospitals, health systems, and physician groups with its comprehensive, end-to-end glycemic management program.”

Scroll to Top